The Automation Partnership Introduces Automated System for Manufacturing Clinical Grade Stem Cells

The Automation Partnership (TAP) has showcased at the European Society for Animal Cell Technology (ESACT) Meeting, CompacT CellBase™, its automated system designed for culturing stem cell and other adherent cell lines in a Good Manufacturing Practice (GMP) environment.

CompacT CellBase, based on TAP’s established CompacT SelecT™ cell culture system, is available with easy to configure cell processing protocols. This can offer cell therapy manufacturers the flexibility to automate cell seeding, expansion, media changing and cell harvesting in an aseptic environment.

An optional module is also available for CompacT CellBase that measures confluence and, at set thresholds, automatically begins cell harvesting, thus maintaining stem cells in an undifferentiated state without any manual intervention.

Using a CompacT CellBase reduces the number of manual processing steps and eliminates the possibility of cross contamination, which means it is ideal for producing cells for use in the clinic.

The system also comes with detailed Installation Qualification (IQ), Operational Qualification (OQ) and support for Performance Qualification (PQ) procedures, making on-site validation in a GMP environment a more straightforward task.